Florida Financial Advisors LLC Purchases Shares of 9,105 Option Care Health, Inc. (NASDAQ:OPCH)

Florida Financial Advisors LLC acquired a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 9,105 shares of the company’s stock, valued at approximately $211,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. FMR LLC boosted its position in shares of Option Care Health by 134.0% in the third quarter. FMR LLC now owns 7,516,448 shares of the company’s stock valued at $235,265,000 after acquiring an additional 4,304,896 shares during the period. Wellington Management Group LLP raised its stake in Option Care Health by 15.5% in the 3rd quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company’s stock worth $310,650,000 after purchasing an additional 1,328,326 shares in the last quarter. Victory Capital Management Inc. boosted its holdings in Option Care Health by 31.1% in the 4th quarter. Victory Capital Management Inc. now owns 2,125,433 shares of the company’s stock valued at $49,310,000 after purchasing an additional 503,840 shares during the period. Magnetar Financial LLC grew its position in shares of Option Care Health by 23.1% during the 4th quarter. Magnetar Financial LLC now owns 2,350,598 shares of the company’s stock worth $54,534,000 after purchasing an additional 441,265 shares in the last quarter. Finally, Edgestream Partners L.P. bought a new position in shares of Option Care Health during the fourth quarter worth approximately $6,932,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

Insider Buying and Selling at Option Care Health

In other news, insider Michael Bavaro sold 30,996 shares of the business’s stock in a transaction dated Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 0.64% of the company’s stock.

Option Care Health Trading Up 1.4 %

OPCH opened at $35.18 on Wednesday. The company has a market cap of $5.78 billion, a P/E ratio of 29.56, a PEG ratio of 2.30 and a beta of 1.33. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The company’s 50 day moving average is $32.11 and its 200-day moving average is $28.33. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.44.

Analysts Set New Price Targets

A number of brokerages recently issued reports on OPCH. UBS Group began coverage on Option Care Health in a research report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price target on the stock. Barrington Research raised their price target on Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a research report on Thursday, February 27th. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and upped their price objective for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. JMP Securities reiterated a “market outperform” rating and set a $30.00 price objective (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research report on Thursday, March 6th. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, Option Care Health presently has an average rating of “Moderate Buy” and a consensus price target of $33.00.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.